BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

TVM Capital Life Science at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

TVM Capital Life Science takes part in 1 session at BIO-Europe 2026 in Cologne. Its program centres on how late-stage investment helps biotech companies scale, alongside BNP Paribas Asset Management, Jeito Capital, Camarco and others. TVM Capital Life Science also sponsors the meeting.

OrganizationBIO-Europe 2026 Attendance
◇Silver Sponsor
Investors & financeSilver sponsor
Life science venture firm investing in early-stage therapeutics and commercial-stage medtech, diagnostics and late-stage therapeutics.
Panel
Tue Nov 10
15:00–15:45
Scaling Success: The Dynamics of Late-Stage Investment in Biotech
How investors back biotechs whose products are close to market, from regulatory hurdles and scaling up to going public or being acquired.
with Camarco, BNP Paribas Asset Management, Jeito Capital +2 more

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at TVM Capital Life Science

Tell us what you sell and we’ll find the people at TVM Capital Life Science most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction